Home Infusion Therapy Market 2021, Share, Size, Trends, Forecast and Analysis of Key Players 2026 briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global home infusion therapy market size is expected to reach USD 44.7 billion by 2028. It is expected to expand at a CAGR of 8.5% from 2021 to 2028.
Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biological products to an individual at home. Favorable government policies and regulations are expected to propel market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law that states that all temporary payments of home infusion therapy in the U.S. will be covered by the government in accordance with this regulation.
Europe Prothrombin Complex Concentrate Market to Grow USD 398.9 Million at 10.9% CAGR till 2027; Rising Adoption of Advanced Bleeding Disorder Management Solutions to Fuel Growth: Fortune Business Insights™ Top Players Covered in the Europe Prothrombin Complex Concentrate Market Research Report are Takeda Pharmaceutical Company Limited (Tokyo, Japan), Kedrion S.p.A (Lucca, Italy), Grifols, S.A. (Barcelona, Spain), Sanquin (Amsterdam, The Netherlands), Octapharma AG (Lachen, Switzerland), CSL Limited (Melbourne, Australia) and other key market players.
February 09, 2021 04:48 ET | Source: Fortune Business Insights Fortune Business Insights
Pune, India, Feb. 09, 2021 (GLOBE NEWSWIRE) The
Europe prothrombin complex concentrate market size is projected to reach USD 398.9 million by 2027, exhibiting a CAGR of 10.9% during the forecast period. The substantial advantages offered by prothrombin complex concentrate (PCC) will be the prim